Our Journey with Venclose

Scope: Create an ablation device for venous disease treatment

Challenge: Develop state-of-the-art RF ablation system, including catheter, generator, control box, software controls and consumables

Outcome: Idea to 510(k) approval and on-the-market treatment in 2.5 years. Production volume increased to hundreds per year. Successfully transferred to a low-cost region.


Venclose was recently acquired by BD for $300M